Kyowa Kirin Co., Ltd. (4151.T)

JPY 2393.0

(0.46%)

Gross Profit Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual gross profit in 2023 was 320.62 Billion JPY , up 2.94% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly gross profit in 2024 Q3 was 95.28 Billion JPY , up 5.25% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported a annual gross profit of 311.45 Billion JPY in annual gross profit 2022, up 17.8% from previous year.
  • Kyowa Kirin Co., Ltd. reported a annual gross profit of 264.39 Billion JPY in annual gross profit 2021, up 11.13% from previous year.
  • Kyowa Kirin Co., Ltd. reported a quarterly gross profit of 76.99 Billion JPY for 2024 Q1, down -22.36% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported a quarterly gross profit of 90.52 Billion JPY for 2024 Q2, up 17.57% from previous quarter.

Annual Gross Profit Chart of Kyowa Kirin Co., Ltd. (2023 - 1999)

Historical Annual Gross Profit of Kyowa Kirin Co., Ltd. (2023 - 1999)

Year Gross Profit Gross Profit Growth
2023 320.62 Billion JPY 2.94%
2022 311.45 Billion JPY 17.8%
2021 264.39 Billion JPY 11.13%
2020 237.91 Billion JPY 5.18%
2019 226.2 Billion JPY -0.44%
2018 227.18 Billion JPY 1.28%
2017 224.32 Billion JPY 7.59%
2016 208.49 Billion JPY -7.5%
2015 225.39 Billion JPY 9.47%
2014 205.9 Billion JPY -3.22%
2013 212.76 Billion JPY 0.98%
2012 210.69 Billion JPY 6.65%
2011 197.55 Billion JPY 3.44%
2010 190.97 Billion JPY 0.0%
2009 - JPY -100.0%
2008 200.29 Billion JPY 38.21%
2007 144.91 Billion JPY 10.27%
2006 131.42 Billion JPY 3.5%
2005 126.98 Billion JPY -3.88%
2004 132.11 Billion JPY 2.01%
2003 129.5 Billion JPY 2.52%
2002 126.32 Billion JPY -1.88%
2001 128.74 Billion JPY 3.87%
2000 123.94 Billion JPY -2.31%
1999 126.87 Billion JPY 0.0%

Peer Gross Profit Comparison of Kyowa Kirin Co., Ltd.

Name Gross Profit Gross Profit Difference
Astellas Pharma Inc. 1212.36 Billion JPY 73.554%
Chugai Pharmaceutical Co., Ltd. 693 Billion JPY 53.735%
Ono Pharmaceutical Co., Ltd. 375.54 Billion JPY 14.625%
Santen Pharmaceutical Co., Ltd. 163.87 Billion JPY -95.649%
JCR Pharmaceuticals Co., Ltd. 31.25 Billion JPY -925.954%
Daiichi Sankyo Company, Limited 1181.79 Billion JPY 72.87%
Otsuka Holdings Co., Ltd. 1407.34 Billion JPY 77.218%
Perseus Proteomics Inc. 87.68 Million JPY -365550.91%